Amcad Biomed (ROCO:4188) EBIT per Share : NT$-0.90 (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed EBIT per Share?

Amcad Biomed's EBIT per Share for the three months ended in Mar. 2025 was NT$-0.31. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-0.90.

During the past 3 years, the average EBIT per Share Growth Rate was -18.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was -2.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Amcad Biomed's EBIT per Share or its related term are showing as below:

ROCO:4188' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -18.2 Med: 0.35 Max: 22.9
Current: -18.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Amcad Biomed was 22.90% per year. The lowest was -18.20% per year. And the median was 0.35% per year.

ROCO:4188's 3-Year EBIT Growth Rate is ranked worse than
77.44% of 718 companies
in the Medical Devices & Instruments industry
Industry Median: 7.45 vs ROCO:4188: -18.20

Amcad Biomed's EBIT for the three months ended in Mar. 2025 was NT$-19.31 Mil.

Amcad Biomed EBIT per Share Historical Data

The historical data trend for Amcad Biomed's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed EBIT per Share Chart

Amcad Biomed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.79

-0.49

-1.00

-0.81

-0.91

Amcad Biomed Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															-0.34	-0.20	-0.33	-0.06	-0.31

Amcad Biomed EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Amcad Biomed's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-52.696	/	57.708
=	-0.91

Amcad Biomed's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-19.31	/	62.316
=	-0.31

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.90

Amcad Biomed (ROCO:4188) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Amcad Biomed EBIT per Share Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Amcad Biomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104

Website

https://www.amcad.com.tw

Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. Geographically, the company generates revenue from Taiwan, China, Europe, Asia (excluding Taiwan and China), and other countries, out of which the majority of the revenue is generated from Taiwan. The company has two segments: the Medical Diagnostic Software segment, which is responsible for the development and sales of smart medical imaging diagnostic software devices, and the Precision Medical Equipment segment, which is responsible for research, development, manufacturing, and sales of high-end ultrasonic probes. The company generates the majority of its revenue from the Precision Medical Equipment segment.

Amcad Biomed Headlines

No Headlines